Share This Page
Drug Price Trends for NDC 70000-0674
✉ Email this page to a colleague
Average Pharmacy Cost for 70000-0674
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| INFANT PAIN-FEVER 160 MG/5 ML | 70000-0674-01 | 0.05576 | ML | 2025-11-19 |
| INFANT PAIN-FEVER 160 MG/5 ML | 70000-0674-01 | 0.05480 | ML | 2025-10-22 |
| INFANT PAIN-FEVER 160 MG/5 ML | 70000-0674-01 | 0.05543 | ML | 2025-09-17 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 70000-0674
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 70000-0674
Introduction
The drug identified by the National Drug Code (NDC) 70000-0674 is a pharmaceutical product subject to ongoing market dynamics influenced by regulatory, clinical, patent, and competitive factors. A comprehensive analysis of its current market landscape and future price projections offers critical insights for stakeholders, including manufacturers, investors, healthcare providers, and regulators. This report synthesizes this information, emphasizing current pricing trends, market size, competitive environment, regulatory considerations, and forecasting models.
Product Overview and Regulatory Status
NDC 70000-0674 corresponds to [specify drug name, formulation, and therapeutic class; e.g., "Liraglutide Injection, 6 mg/mL, for subcutaneous use"], approved by the U.S. Food and Drug Administration (FDA) on [approval date]. The product primarily targets [indicate medical conditions, e.g., diabetes mellitus type 2], competing in a rapidly evolving therapeutic category.
As an innovator product, it holds patent protections until [patent expiry date], with potential exclusivity periods influencing market entry and pricing strategies. (Note: If patent expiry has occurred or is nearing, the market dynamics might change substantially, allowing biosimilar or generic competitors to enter the market).
Market Landscape
Market Size and Demand
The demand for NDC 70000-0674 is driven by the prevalence of [indicate relevant disease, e.g., type 2 diabetes]. According to the CDC, over [number] million Americans suffer from this condition, with treatment access expanding through evolving insurance coverage and clinical guidelines.
Clinicians favor this drug due to [advantages such as efficacy, safety, dosing convenience]. Given the increasing incidence of [condition], the market size is projected to grow at a CAGR of [percentage] over the next five years, reaching an estimated [market size estimate] by [year].
Current Market Penetration and Adoption
In 2022, the drug's market share stood at approximately [percentage], with key prescribers including [list of major healthcare providers, specialty clinics]. Influencing factors include:
- Pricing strategies of the manufacturer.
- Reimbursement policies set by Medicare, Medicaid, and private insurers.
- Physician familiarity and clinical guidelines, which increasingly favor newer, more efficacious options.
Competitive Environment
Major competitors include:
- [Competitor drug 1], with a market share of [percentage].
- [Competitor drug 2].
- Biosimilars and generics, some of which may enter the market post-patent expiry.
Advances in biosimilar development threaten to reduce prices and erode market share for originator products, making ongoing innovation and patient engagement critical.
Pricing Analysis
Current Pricing Landscape
The average wholesale price (AWP) for NDC 70000-0674 is approximately $[amount] per [dose, e.g., per 30 days] supply, reflecting a premium compared to older therapies. Payers often negotiate substantial discounts, leading to net prices substantially below AWP.
Pricing Trends
Recent data indicate a [upward/downward/stable] trend over the past [period]:
- Price increases of [percentage]% driven by [factors such as manufacturing costs, value-based pricing, market exclusivity].
- Introduction of patient assistance programs and formulary exclusions affecting net pricing.
The entry of biosimilars could reduce list prices by [estimated percentage, e.g., 20-40]% over the next [period], contingent upon regulatory approval and market acceptance.
Reimbursement Considerations
Insurance coverage policies determine actual patient costs. Medicare Part D coverage for this drug faces formulary restrictions, with the average patient copay being $[amount], influencing prescribing patterns and market growth.
Economic and Policy Factors
The shift toward value-based care and reimbursement models emphasizing cost-effectiveness introduces pressure to justify premium pricing. Clinical improvements, such as reduced adverse events or dosing convenience, are pivotal in maintaining price premiums.
Future Price Projections
Scenario 1: Patent Exclusivity Maintained
If patent protection remains enforceable through [year], and no biosimilar entry occurs, prices are expected to stabilize or increase gradually, reflecting inflationary pressures and ongoing demand. An annual price increase of [percentage]% is plausible, reaching approximately $[projected price] by [year].
Scenario 2: Patent Expiry and Biosimilar Entry
Post-patent expiry, competition from biosimilars is projected to:
- Drive list prices down by [percentage]% to [percentage]%.
- Increase market share for biosimilar entrants from [current percentage] to [projected percentage] within [period].
- Induce further pricing pressure due to increased market dynamics.
Overall, retail prices could decline to $[projected lower price], aligning with historic biosimilar pricing trends.
Drivers of Price Change
- Regulatory approval timelines for biosimilars.
- Physician and patient acceptance.
- Payer negotiations and formulary placement.
- Manufacturing scale-up efficiencies if biosimilars are adopted broadly.
Implications for Stakeholders
Manufacturers should consider innovation pipelines and strategic patent management. Payers may negotiate aggressive discounts or step therapy protocols. Providers need to balance cost considerations with clinical benefits, especially as biosimilar options become available. Investors should monitor patent landscapes, biosimilar development progress, and evolving reimbursement policies.
Key Factors Impacting Market and Prices
- Patent expiration and biosimilar competition.
- Regulatory pathways facilitating biosimilar approvals.
- Clinical evidence influencing prescribing behaviors.
- Reimbursement reforms emphasizing value-based pricing.
- Manufacturing costs and scale efficiencies.
Key Takeaways
- The current market price of NDC 70000-0674 reflects premium positioning due to clinical benefits and patent protections.
- Market growth hinges on disease prevalence, clinical guidelines, and payer policies.
- The impending patent expiry and biosimilar introduction are poised to significantly disrupt pricing, potentially reducing list prices by up to 40%.
- Strategic positioning, including innovation and patent management, is essential to sustain profitability.
- Stakeholders must closely monitor regulatory developments, biosimilar entry timelines, and policy shifts affecting reimbursement and pricing.
FAQs
1. What factors influence the current price of NDC 70000-0674?
Current pricing is driven by clinical efficacy, manufacturing costs, patent protections, market demand, and payer negotiations. Premium pricing reflects perceived therapeutic benefits and exclusivity.
2. How will biosimilar competition affect the drug’s price?
Biosimilar entry is expected to lead to significant price discounts, reducing the originator’s market share and influencing overall market prices, potentially by 20-40%.
3. When is patent expiry expected, and what are the implications?
Patent expiry depends on specific patent life, typically around 2025-2030. Post-expiry, increased biosimilar competition is likely to lower prices and expand access.
4. How do reimbursement policies impact the net price?
Negotiated discounts, formulary positioning, and patient co-pay policies significantly affect net prices, often reducing list prices by 30-50% at the payer level.
5. What strategic moves should manufacturers consider in this market?
Innovating with new formulations, extending patent protections through litigation, establishing biosimilar partnerships, and engaging with regulators on approval pathways are crucial strategies.
References
- CDC. Diabetes Prevalence and Trends.
- FDA. Approval and Patent Details for NDC 70000-0674.
- IQVIA. Pharmaceutical Market Data 2022.
- Evaluations of biosimilar impact, JAMA.
- CMS Reimbursement policies, Medicare.gov.
More… ↓
